{"id":"W7042403271","doi":"","title":"Proteon Therapeutics Announces Second Quarter 2017 Financial Results","year":2017,"lang":"en","type":"other","venue":"","topic":"Transgenic Plants and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Financial management; Payment","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003370048,0.0009854955,0.0006884364,0.00132467,0.00157067,0.006234392,0.001249756,0.004693184,0.3120785],"category_scores_gemma":[0.003973996,0.0003453683,0.0009430297,0.0006291931,0.0009657292,0.002134718,0.002033018,0.004590039,0.1957592],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002837335,"about_ca_system_score_gemma":0.007240095,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003875052,"about_ca_topic_score_gemma":0.01084983,"domain_scores_codex":[0.9975379,0.0001442752,0.0000418097,0.0001580776,0.001594166,0.0005237266],"domain_scores_gemma":[0.996418,0.0002638063,0.0001474053,0.0001390784,0.001044256,0.001987487],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001055189,0.00008966607,0.00008799335,0.00002061438,0.000003035381,0.00004431183,0.000004391723,0.00005641615,0.0002877362,0.002414718,0.9794767,0.0174088],"study_design_scores_gemma":[0.0001323639,0.0001474819,0.0005185697,0.0000506406,0.000007123454,0.00008754068,0.00002593617,0.0005861062,0.0008542832,0.003488926,0.9940856,0.00001543744],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.002744395,0.002638947,0.003274962,0.05464363,0.02653915,0.0004505274,0.00797616,0.004211499,0.8975207],"genre_scores_gemma":[0.005120317,0.000997585,0.0005739158,0.007607813,0.002416174,0.0001062307,0.003587249,0.00049927,0.9790913],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.3120785,"threshold_uncertainty_score":0.9812366,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01905192593890967,"score_gpt":0.2729023654817017,"score_spread":0.2538504395427921,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}